X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (890) 890
sulbactam - therapeutic use (636) 636
female (543) 543
ampicillin - therapeutic use (521) 521
male (507) 507
anti-bacterial agents - therapeutic use (386) 386
sulbactam (377) 377
adult (337) 337
middle aged (328) 328
drug therapy, combination - therapeutic use (280) 280
aged (266) 266
index medicus (264) 264
pharmacology & pharmacy (256) 256
infectious diseases (236) 236
microbial sensitivity tests (227) 227
microbiology (224) 224
antibiotics (187) 187
bacterial infections - drug therapy (186) 186
sulbactam - administration & dosage (183) 183
drug therapy, combination (179) 179
infections (173) 173
adolescent (170) 170
sulbactam - pharmacology (169) 169
treatment outcome (144) 144
ampicillin (139) 139
ampicillin - administration & dosage (133) 133
anti-bacterial agents - pharmacology (133) 133
child (133) 133
drug combinations (129) 129
beta-lactamase inhibitors (122) 122
aged, 80 and over (116) 116
animals (115) 115
acinetobacter infections - drug therapy (114) 114
ampicillin - pharmacology (112) 112
child, preschool (108) 108
cefoperazone - therapeutic use (105) 105
acinetobacter baumannii - drug effects (103) 103
infant (95) 95
prospective studies (94) 94
sulbactam - adverse effects (94) 94
penicillanic acid - therapeutic use (92) 92
anti-bacterial agents - administration & dosage (91) 91
bacteria (91) 91
ampicillin - adverse effects (86) 86
acinetobacter baumannii (84) 84
sulbactam - pharmacokinetics (82) 82
drug resistance (80) 80
bacterial infections - microbiology (76) 76
infection (76) 76
retrospective studies (76) 76
acinetobacter infections - microbiology (75) 75
drug resistance, multiple, bacterial (74) 74
clavulanic acid (72) 72
epidemiology (72) 72
drug therapy, combination - pharmacology (71) 71
colistin (69) 69
tazobactam (69) 69
biochemical phenomena, metabolism, and nutrition (68) 68
surgery (67) 67
bacteria - drug effects (65) 65
health aspects (62) 62
ampicillin - pharmacokinetics (61) 61
bacteremia (60) 60
imipenem (60) 60
pneumonia (60) 60
ampicillin-sulbactam (59) 59
nosocomial infections (58) 58
immunology (56) 56
efficacy (54) 54
respiratory tract infections - drug therapy (54) 54
antimicrobial agents (53) 53
pediatrics (53) 53
polycyclic compounds (53) 53
research article (53) 53
therapy (53) 53
penicillins - therapeutic use (52) 52
risk factors (52) 52
cross infection - drug therapy (51) 51
ampicillin/sulbactam (50) 50
mortality (50) 50
acinetobacter baumannii - isolation & purification (49) 49
bacterial infections and mycoses (49) 49
drug resistance, microbial (49) 49
drug therapy (49) 49
bacteria - isolation & purification (48) 48
combination (48) 48
drug evaluation (48) 48
drug synergism (48) 48
medicine, general & internal (48) 48
pregnancy (48) 48
surgical wound infection - prevention & control (48) 48
drug resistance in microorganisms (47) 47
drug resistance, bacterial (47) 47
injections, intravenous (47) 47
pseudomonas-aeruginosa (47) 47
research (47) 47
analysis (46) 46
penicillanic acid - analogs & derivatives (46) 46
pharmacokinetics (46) 46
staphylococcal infections - drug therapy (46) 46
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (970) 970
Japanese (69) 69
Russian (30) 30
German (14) 14
Turkish (13) 13
Chinese (12) 12
Italian (12) 12
Spanish (12) 12
Polish (10) 10
French (7) 7
Czech (3) 3
Romanian (2) 2
Bulgarian (1) 1
Korean (1) 1
Lithuanian (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Antimicrobial Agents, ISSN 0924-8579, 2011, Volume 39, Issue 2, pp. 105 - 114
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2015, Volume 60, Issue 9, pp. 1295 - 1303
Background. With an increase in the use of colistin methansulfonate (CMS) to treat carbapenem-resistant Acinetobacter baumannii infections, colistin resistance... 
Acinetobacter baumannii | Molecular typing | Carbapenem resistance | Colistin resistance | Lipid A | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | lipid A | molecular typing | MICROBIOLOGY | IMMUNOLOGY | EMERGENCE | carbapenem resistance | PMRCAB OPERON | SURVEILLANCE | LIPOPOLYSACCHARIDE | colistin resistance | PHOSPHOETHANOLAMINE MODIFICATION | MOLECULAR EPIDEMIOLOGY | MULTIDRUG-RESISTANCE | INSIGHTS | Humans | Middle Aged | Sulbactam - therapeutic use | Male | Acinetobacter Infections - mortality | Multilocus Sequence Typing | Microbial Sensitivity Tests | Carbapenems - pharmacology | Colistin - pharmacology | Drug Resistance, Multiple, Bacterial | Aged, 80 and over | Acinetobacter baumannii - isolation & purification | Adult | Colistin - therapeutic use | Female | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Lipid A - chemistry | Acinetobacter Infections - microbiology | Pneumonia, Ventilator-Associated - drug therapy | Acinetobacter Infections - complications | Ampicillin - therapeutic use | Acinetobacter Infections - drug therapy | Acinetobacter baumannii - pathogenicity | Ethanolamines - chemistry | Electrophoresis, Gel, Pulsed-Field | Carbapenems - therapeutic use | Pneumonia, Ventilator-Associated - microbiology | Aged | Acinetobacter baumannii - drug effects | Acinetobacter baumannii - genetics | Electronic Health Records | Dosage and administration | Research | Colistin | Drug resistance | and Commentaries
Journal Article
Journal Article
Journal Article
JAMA Surgery, ISSN 2168-6254, 05/2016, Volume 151, Issue 5, pp. 432 - 439
Journal Article
Journal Article
European Journal of Clinical Microbiology & Infectious Diseases, ISSN 0934-9723, 8/2014, Volume 33, Issue 8, pp. 1311 - 1322
Journal Article